Prime Minister Sonexay Siphandone (centre) cuts the ribbon to officially open the new factory on Friday, accompanied by government officials and company representatives.

Lao Alliance expands pharmaceutical production with factory no. 2

The Lao Alliance Pharmaceutical Factory No. 2 officially opened its doors on Friday at Simmano village, Hadxayfong district, Vientiane, marking a major step forward in Laos’ efforts to strengthen its pharmaceutical production and promote national healthcare development.
The opening ceremony was graced by Prime Minister Sonexay Siphandone, who presided over the event, alongside Deputy Minister of Health Dr Aphone Vixathep, company executives, government officials, representatives from international organisations, and invited guests.

Ms Kimmy Savatvyphane, Chief Executive Officer of Lao Alliance Pharmaceutical Factory No. 2, addresses guests at the factory opening ceremony on Friday.

The new factory, operated by Lao Alliance Pharmaceutical Group (LAPG), represents a US$150 million investment in advanced pharmaceutical manufacturing. The facility is equipped with modern technology that meets international standards, positioning it as one of the country’s most sophisticated pharmaceutical production bases.
In her address, Dr Aphone Vixathep, Deputy Minister of Health, praised the factory as a significant milestone in the development of the pharmaceutical industry in Laos, and commended the investors and developers for their contribution to improving public health.

She said “This factory is a state-of-the-art facility that meets international standards and will play a crucial role in increasing the production of quality medicines in Laos,” Dr Aphone said. “Its products will not only serve the domestic market but also have the potential to reach international markets.”
She added that the Ministry of Health would continue to provide regulatory support to ensure the factory operates in full compliance with safety and quality standards.
Chief Executive Officer of the Lao Alliance Pharmaceutical Factory No. 2, Ms Kimmy Savatvyphane, expressed gratitude to the government and all partners for their support and trust.
“Today is a historic day filled with pride,” Ms Kimmy said. “This factory is not only an expansion of our capacity but also a commitment to producing safe, effective, and affordable medicines for the Lao people.”
She noted that the new facility will focus on producing essential and advanced biotech medicines, create new employment opportunities, and develop local expertise in modern pharmaceutical manufacturing.
“We are deeply honoured by the presence of the Prime Minister and high-ranking officials,” she said. “Their attendance reflects the government’s strong vision for the growth of the pharmaceutical and healthcare sectors.”
The Lao Alliance Pharmaceutical Factory No. 2 stands as a testament to Laos’ growing capability in the health and industrial sectors, paving the way for greater self-sufficiency in medicine production and enhanced healthcare access for its people.
As Ms Kimmy concluded, “LAPG will continue to invest in research, development, and innovation  building a healthier future for Laos.”

By Times Reporters
(Latest Update October 20, 2025)